Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
Authors:
- Gerrit ToengesGTGerrit Toenges
- Anna C MavromanoliAMAnna C Mavromanoli
- Walter AgenoWAWalter Ageno
- Marianne BrodmannMBMarianne Brodmann
- Francis CouturaudFCFrancis Couturaud
- Claudia DellasCDClaudia Dellas
- Konstantinos DimopoulosKDKonstantinos Dimopoulos
- Daniel DuerschmiedDDDaniel Duerschmied
- Klaus EmpenKEKlaus Empen
- 1 September 2021
- journal article
- research article
- Published by Elsevier in The Lancet Haematology
- Vol. 8 (9) , e627-e636
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01EO1003, 01EO1503)
- Johannes Gutenberg-Universität Mainz
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Boehringer Ingelheim
- Deutscher Akademischer Austauschdienst (57440918)
- Deutsches Zentrum für Herz-Kreislaufforschung
This publication has 31 references indexed in Scilit:
- Fibrinolysis for Patients with Intermediate-Risk Pulmonary EmbolismNew England Journal of Medicine, 2014
- Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2014
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled AnalysisCirculation, 2014
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous ThromboembolismNew England Journal of Medicine, 2013
- Oral Apixaban for the Treatment of Acute Venous ThromboembolismNew England Journal of Medicine, 2013
- The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and deathResuscitation, 2013
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary EmbolismNew England Journal of Medicine, 2012
- Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: Rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trialAmerican Heart Journal, 2012
- Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismNew England Journal of Medicine, 2009
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005